- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02069327
The Role of Fat Emboli in the Trauma Inflammatory Response
March 18, 2019 updated by: Julie Dunn, M.D., Poudre Valley Health System
This is an observational study designed to investigate the role of fat emboli in patients who are undergoing a tibial or femoral fracture procedure in the operating room.
The purpose of this study is to obtain samples of bone marrow and blood during tibial or femoral fracture procedures to understand the inflammatory response.
Study Overview
Status
Completed
Conditions
Detailed Description
Bone marrow is routinely removed during a tibial or femoral fracture procedure; researchers will take samples for this study from bone marrow that has already been removed as part of this procedure.
No additional marrow samples will be taken as part of this research study.
Also, researchers will collect blood (about 4 teaspoons) for testing inflammatory response and coagulation.
Researchers may need to insert an additional line to collect your blood.
Study Type
Observational
Enrollment (Actual)
9
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Loveland, Colorado, United States, 80538
- Medical Center of the Rockies
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients undergoing a tibial or femoral fracture procedure in the operating room.
Description
Inclusion Criteria:
- Patients undergoing a tibial or femoral fracture procedure in the operating room.
Exclusion Criteria:
- n/a
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Inflammatory Response
Time Frame: One day
|
Samples will be tested using proteomic and metabolomic assays from samples of bone marrow reamed during intramedullary (IM) femoral nailing. Blood samples drawn at the time of IM nailing will be tested to determine if clinically relevant amounts of marrow containing these inflammatory mediators are released into the bloodstream. |
One day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Julie Dunn, M.D., Poudre Valley Health System
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2012
Primary Completion (Actual)
July 1, 2014
Study Completion (Actual)
November 1, 2014
Study Registration Dates
First Submitted
February 3, 2014
First Submitted That Met QC Criteria
February 19, 2014
First Posted (Estimate)
February 24, 2014
Study Record Updates
Last Update Posted (Actual)
March 20, 2019
Last Update Submitted That Met QC Criteria
March 18, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Fat Emboli
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Femoral Fracture
-
Sundsvall HospitalCompletedHip Fracture | Femoral Neck Fracture | Periprosthetic Femoral Fracture
-
Zimmer BiometTerminatedFemur Fracture | Garden Grade I Subcapital Fracture of Femoral Neck | Garden Grade II Subcapital Fracture of Femoral Neck | Femur Fracture Intertrochanteric | Garden Grade III Subcapital Fracture of Femoral Neck | Garden Grade IV Subcapital Fracture of Femoral NeckUnited States
-
Mahidol UniversityCompletedHip Fracture | Femoral Neck Fracture | Intertrochanteric FractureThailand
-
University of NairobiCompletedHip Fracture | Femoral Neck Fracture | Fracture Neck of Femur
-
NYU Langone HealthCompletedHip Fractures | Femoral Shaft FracturesUnited States
-
AO Innovation Translation CenterCompletedA Focused Registry on the Femoral Neck System (FNS) in Patients With Femoral Neck Fractures (FR_FNS)Hip Fracture | Femoral Neck FractureAustria, Switzerland, Germany
-
Danderyd HospitalActive, not recruitingHip Fracture | Femoral Neck FractureSweden
-
Sundsvall HospitalCompletedHip Fracture | Femoral Neck Fracture
-
Aeos Biomedical Inc.TerminatedFemoral Fracture | Tibial FractureCanada